University of Birmingham in conjunction with M3 conducted a research study to investigate how 20,996 healthcare professionals in 29 countries might use SARS-CoV-2 antigen and antibody tests in COVID-19 cases.
Ekas proudly contributed the Australian data for this research by reaching out to our healthcare panel. These results will without doubt have a significant impact in how these tests are launched both in the UK and globally.
Click the following link to read the findings of this important research.
Global COVID-19 Testing Results